Page 38 - PCC07

The PCO Syndrome from Diagnosis to Health Risk Management:
Androgen Excess: Is it the driving force behind the syndrome and its health implications?
Joop S.E. Laven, M.D., Ph.D.,
Division of Reproductive Endocrinology & Infertility, Department of Obstetrics and Gynaecology, Erasmus MC, Rotterdam,
The Netherlands.
Disclosures
 Past President of the Dutch Society for Reproductive Medicine (DSRM)
 Past Chairman of the Task force Reproductive Endocrinology of the Royal Dutch College of Obstetrics and
Gynaecology (RDCOG)
 Received unrestricted research grants from Ferring®, Merck Serono®, MSD®, Organon®, Serono® and Shering-Plough®
 Received consultancy fees from Ferring®, Danone®, Euroscreen®, AnshLabs®, Roche International®
 Received grants from the Erasmus Trust Fund and from Erasmus MC Holding
 Received grants from the Dutch Genomics Initiative and form the Dutch Heart Association
 Past Member of the Editorial Board of Human Reproduction
 Member of the Editorial Board of Human Reproduction Update and Journal of the Endocrine Society
Page 31 of 196
38